Sarepta Therapeutics Inc.

In News

Sarepta Therapeutics, Inc.'s (NASDAQ:SRPT) Shares Bounce 26% But Its Business Still Trails The Industry - 富途牛牛

富途牛牛 - Dec 07, 2025

Edgestream Partners L.P. Purchases 74,427 Shares of Sarepta Therapeutics, Inc. $SRPT - MarketBeat

MarketBeat - Dec 06, 2025

Why Is Sarepta Therapeutics (SRPT) Up 26.4% Since Last Earnings Report? - Yahoo Finance

Yahoo Finance - Dec 03, 2025

There's No Escaping Sarepta Therapeutics, Inc.'s (NASDAQ:SRPT) Muted Revenues Despite A 35% Share Price Rise - simplywall.st

simplywall.st - Dec 04, 2025

Sarepta Announces FDA’s Approval of Updated ELEVIDYS Prescribing Information - Sarepta Therapeutics

Sarepta Therapeutics - Nov 14, 2025

How Sarepta Therapeutics Inc. (AB3A) stock expands through international markets - Weekly Trade Analysis & Safe Swing Trade Setups - Newser

Newser - Dec 05, 2025

Sarepta gets FDA's go-ahead to study immunosuppressive Elevidys regimen in bid to reverse label restriction - Fierce Pharma

Fierce Pharma - Nov 25, 2025

Sarepta shares tumble on trial failure, weak Elevidys outlook - Reuters

Reuters - Nov 04, 2025

Sarepta Therapeutics Announces Third Quarter 2025 Financial Results and Recent Corporate Developments, Including Completion of Its Confirmatory Study, ESSENCE - Sarepta Therapeutics

Sarepta Therapeutics - Nov 03, 2025

Sarepta Therapeutics (NASDAQ:SRPT) Shares Gap Down - Time to Sell? - MarketBeat

MarketBeat - Dec 04, 2025

Sarepta Therapeutics Inc (SRPT) Q3 2025 Earnings Call Highlights: Resilient Revenue Amidst ... - Yahoo Finance

Yahoo Finance - Nov 03, 2025

Sarepta Therapeutics Announces Strategic Restructuring and Pipeline Prioritization Plan to Maintain Long-term, Sustainable Growth and Provides Update on ELEVIDYS Label - Sarepta Therapeutics

Sarepta Therapeutics - Jul 16, 2025

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment